STOCKSCOPE

Euroz Hartleys (ASX: EZL) Completes $145M BMO Sale, but What Is Its Remaining Wealth Business Worth?

Mark Elzayed

Mark Elzayed

CIO at Vestra Capital

Published:6d ago
Euroz Hartleys (ASX: EZL) Completes $145M BMO Sale, but What Is Its Remaining Wealth Business Worth?

A $145 million asset sale has reshaped Euroz Hartleys Group Limited (ASX: EZL), with shareholders expected to receive approximately 61.4 cents per share through a special dividend and capital return.

The completion of its Capital Markets sale to BMO on 2 November 2026 provides a substantial near-term capital return. However, the more consequential question is whether the remaining Private Wealth business can generate sustainable earnings after losing its more profitable division.

Key numbers

  • $145 million: Gross cash consideration for the completed Capital Markets sale, subject to completion adjustments.
  • 61.4 cents per share: Approximate anticipated combined special dividend and capital return, subject to final confirmation.
  • $71.25 million: FY2026 revenue generated by the remaining Private Wealth segment.
  • $5.10 million: FY2026 Private Wealth segment operating profit after tax.
  • $5.17 billion: Funds under management at 30 June 2026, representing 16.1% annual growth.

BMO transaction completes a major business transformation

Euroz Hartleys confirmed on 2 November that it had completed the sale of its Capital Markets operations to BMO Australia Pty Limited, a subsidiary of Bank of Montreal.

The transaction follows the binding agreement announced in June and shareholder approval obtained in October.

Management expects to distribute the post-tax net proceeds through a fully franked special dividend and an equal-sized return of capital.

The combined distribution is estimated at approximately 61.4 cents per share, implying an indicative 30.7 cents through each component.

However, final amounts, record dates and payment dates remain subject to confirmation.

The company previously disclosed an estimated $38.7 million corporate tax liability associated with the transaction.

Consequently, the $145 million headline consideration should not be confused with the cash ultimately available for distribution.

The transaction also activates a four-year strategic alliance with BMO, supported by trading, clearing, settlement and transitional service arrangements.

These arrangements could preserve access to institutional capabilities without requiring Euroz Hartleys to maintain its former Capital Markets infrastructure.

What stands out to us

The most revealing figures are the historical earnings of the business Euroz Hartleys retains.

In FY2026, Private Wealth generated $71.25 million in revenue and $5.10 million in operating profit after tax.

Its operating profit before tax was $7.54 million, representing a margin of approximately 10.6%.

By comparison, the divested Capital Markets division generated $67.46 million in revenue and $9.99 million in operating profit after tax.

This means the operation being sold historically generated almost twice the after-tax operating profit of Private Wealth, despite reporting slightly lower revenue.

The remaining business also has a more transactional revenue mix than its wealth management positioning might suggest.

FY2026 wealth management fees totalled $25.12 million, while brokerage contributed $31.18 million and underwriting and placement activities generated $12.82 million.

These figures indicate that Private Wealth retains meaningful exposure to market activity rather than relying entirely on predictable recurring fees.

Its historical $5.10 million segment profit provides a valuation starting point, but future standalone earnings will depend on corporate overheads, operating costs and post-sale arrangements.

What the company is doing now

Euroz Hartleys is concentrating on private wealth services through its Euroz Hartleys and Entrust brands.

The business manages approximately $5 billion in client assets and operates an advisory network of around 60 professionals.

Alan Logan has assumed the chief executive role as the company implements its post-transaction structure.

Management's priorities include adviser retention, client growth and improving operational efficiency.

The BMO alliance may support these objectives, although its financial contribution remains unquantified.

Insight: Can Private Wealth Justify Its Valuation After the Capital Return?

We think Euroz Hartleys has created a clearer business structure by monetising Capital Markets, but the transaction does not automatically strengthen the profitability of the remaining company. Private Wealth's $71.25 million historical revenue base provides scale, yet its $5.10 million segment after-tax profit highlights relatively modest earnings conversion. Brokerage and underwriting exposure also limits the predictability of income. Our assessment is cautiously constructive, although a credible standalone valuation requires clearer corporate cost allocations, recurring fee growth and evidence of sustainable free cash flow following the shareholder distribution.

What happens next?

The immediate catalyst is confirmation of the final special dividend, capital return and payment timetable.

Beyond that, standalone financial reporting will be decisive.

Shareholders should monitor funds under management, adviser retention, brokerage activity, operating margins and free cash flow.

The completed sale provides an immediate capital return, but the longer-term value of Euroz Hartleys will depend on whether its smaller wealth management business can convert client relationships and recurring fees into stronger, sustainable profits.

Mark Elzayed

Mark Elzayed

(CIO at Vestra Capital)

Mark Elzayed is a prominent Australian financial executive and portfolio strategist with over a decade of hands-on capital markets experience. Having successfully managed over $100M+ in FUM across volatile economic cycles, Mark founded Vestra Capital to democratize institutional-grade quantitative strategies and privileged ASX deal flow for Australian investors.

DisclaimerInformation on Stockscope is general in nature and does not constitute financial product advice. It does not take into account your personal objectives, financial situation or needs. Seek independent advice from a qualified financial adviser before making an investment decision. Stockscope and its affiliates do not guarantee the accuracy or completeness of information published on this website. To the extent permitted by law, they accept no liability for any claim, loss or damage arising from its use or reliance on it. Stockscope and its associates may have commercial relationships with companies featured on this website, hold securities in those companies, or receive commissions in connection with capital raisings.

Continue Reading

ASX Weathers Wall Street's AI Rout, but Three Market Risks Are Becoming Harder to Ignore
Market Briefings
Market Briefings

ASX Weathers Wall Street's AI Rout, but Three Market Risks Are Becoming Harder to Ignore

Australian equities: what moved the ASX 200? Australian shares finished lower on Friday, 6 November, as the technology-led sell-off on Wall Street spread across global markets. The ASX 200...

Mark ElzayedMark Elzayed•
Epiminder (ASX: EPI) Expands FDA Clearance as $65 Million Cash Reserve Faces a Crucial Commercial Test
Biotech & Health
Biotech & Health

Epiminder (ASX: EPI) Expands FDA Clearance as $65 Million Cash Reserve Faces a Crucial Commercial Test

Epiminder Limited ASX: EPI has expanded the US market for its epilepsy monitoring technology following a significant regulatory clearance, strengthening its commercial prospects ahead of a p...

Danny AadDanny Aad•
Asara Resources (ASX: AS1) Hits 38m at 2.1g/t Gold: Could Sogosogoba Unlock Kada's Next Growth Phase?
Mining
Mining

Asara Resources (ASX: AS1) Hits 38m at 2.1g/t Gold: Could Sogosogoba Unlock Kada's Next Growth Phase?

A 38-metre gold intersection grading 2.1 grams per tonne has given Asara Resources Limited ASX: AS1 an encouraging exploration result beyond its established Massan deposit in Guinea. The dis...

Alison ElzayedAlison Elzayed•
Alvo Minerals (ASX: ALV) Expands Rare Earth Discovery Across 6.5km², but Can It Deliver Economic Value?
Mining
Mining

Alvo Minerals (ASX: ALV) Expands Rare Earth Discovery Across 6.5km², but Can It Deliver Economic Value?

Alvo Minerals Limited ASX: ALV has extended rare earth mineralisation approximately 2 kilometres beyond previously tested areas at its Boa Vista prospect in Brazil, strengthening the explora...

Alison ElzayedAlison Elzayed•
Avenira Limited (ASX: AEV) Raises $48.9 Million as Wonarah Phosphate Project Faces Its Biggest Test Yet
Mining
Mining

Avenira Limited (ASX: AEV) Raises $48.9 Million as Wonarah Phosphate Project Faces Its Biggest Test Yet

Avenira Limited ASX: AEV has reached a significant financing milestone, with its $48.9 million rights issue providing fresh capital to advance the Wonarah Phosphate Project in the Northern T...

Alison ElzayedAlison Elzayed•
Mayne Pharma Group (ASX: MYX) Unveils $55.5 Million Sale, but Can Its US Business Deliver Stronger Profits?
Biotech & Health
Biotech & Health

Mayne Pharma Group (ASX: MYX) Unveils $55.5 Million Sale, but Can Its US Business Deliver Stronger Profits?

Mayne Pharma Group Limited ASX: MYX is taking a decisive step towards becoming a US-focused pharmaceutical company, agreeing to sell its international operations for $55.5 million. The tran...

Danny AadDanny Aad•
Loading more stories...